| Literature DB >> 34150359 |
Atmaram Yarlagadda1,2,3,4,5,6, Samuel L Preston1,2,3,4,5,6, Rachel P Jeyadhas1,2,3,4,5,6, Adam Edward Lang1,2,3,4,5,6, Rasha Hammamieh1,2,3,4,5,6, Anita H Clayton1,2,3,4,5,6.
Abstract
Neuropsychiatric manifestations of COVID-19 have become increasingly common in published literature as the COVID-19 pandemic continues to devastate the world. Morbidity and mortality associated with COVID-19 infection is driving recognition of the need for potential research in prevention, effective treatment, and reducing fatalities. In this article, we highlighted discussions and proposals previously reported in our series of articles on the subject of the blood-brain barrier to prevent both neurological and psychiatric manifestations of viral infection. The time for a rapid translational approach to bring point-of-care diagnostics and early prevention/treatment tools to practice is now, and it deserves immediate attention.Entities:
Keywords: COVID-19; Cytokine Norms; blood-brain barrier; cytokine signature; pandemics
Year: 2021 PMID： 34150359 PMCID： PMC8195557
Source DB: PubMed Journal: Innov Clin Neurosci ISSN： 2158-8333